GSK-467 Chemical Properties

Boiling point:

560.6±60.0 °C(Predicted)

Density 

1.41±0.1 g/cm3(Predicted)

storage temp. 

2-8°C

solubility 

DMSO : 20.83 mg/mL (65.23 mM);Water : < 0.1 mg/mL (insoluble)

pka

2.27±0.20(Predicted)

form 

Solid

color 

White to off-white

Safety Information

HS Code 

2933998090

GSK-467 Usage And Synthesis

Uses

GSK467 is a cell penetrant and selective KDM5B (JARID1B or PLU1) inhibitor with a Ki of 10 nM and an IC50 of 26 nM. GSK467 shows 180-fold selectivity for KDM4C and no measurable inhibitory effects toward KDM6 or other Jumonji family members[1][2].

in vivo

IC 50

KDM5: 10 nM (Ki); KDM5: 26 nM (IC₅₀)

References

[1] Johansson C, et al. Structural analysis of human KDM5B guides histone demethylase inhibitor development. Nat Chem Biol. 2016 Jul;12(7):539-45. DOI:10.1038/nchembio.2087
[2] Fu YD, et al. Targeting histone demethylase KDM5B for cancer treatment. Eur J Med Chem. 2020 Dec 15;208:112760. DOI:10.1016/j.ejmech.2020.112760
[3] Guo JC, et al. KDM5B promotes self-renewal of hepatocellular carcinoma cells through the microRNA-448-mediated YTHDF3/ITGA6 axis. J Cell Mol Med. 2021 Apr 7;25(13):5949–62. DOI:10.1111/jcmm.16342

GSK-467(1628332-52-4)Related Product Information

• RET Kinase inhibitor 1
• N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-3-methyl-6-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide
• GSK484
• GSK583
• GSK369796
• GSK461364
• GSK547
• GSK481
• GSK-3326595
• 4-Chloro-N-[2-[[5-(trifluoromethyl)-2-pyridinyl]sulfonyl]ethyl]benzamide